XML 45 R27.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS	12 Months Ended
SUBSEQUENT EVENTS	Dec. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS Ligand Milestone Payment Pursuant to the Ligand License Agreement, the Company is obligated to make a $23.0 million milestone payment to Ligand (and BMS) in the first quarter of 2023, as a result of the accelerated approval granted to FILSPARI (sparsentan). Upon payment, the $23.0 million will be capitalized as an intangible asset on the Consolidated Balance Sheets.